JPRN-UMIN000002629尚未招募未知
Association of efficacy of long acting beta 2-agonist (LABA) and single nucleotide polymorphisms (SNP) of beta 2-adrenergic receptors in elderly patients with COPD - Efficacy of LABA and SNP of beta 2-adrenergic receptors
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria included age younger than 65, dementia and any previously usage of inhaled medications such as beta 2-agonists, anti-cholinergics or corticosteroids, patched beta 2--agonist, or systemic corticosteroids. Patients with dermatological disorders, severe heart diseases, uncontrolled hypertension or other diseases for whom patch preparations or treatments with beta 2-agonists was considered inappropriate were also excluded.
研究者
相似试验
已完成
不适用
Efficacy and safety of long-acting beta-2 agonist and long-acting muscarinic antagonist combinations in patients with chronic obstructive pulmonary disease: meta-analysis of phase 3 randomized trialschronic obstructive pulmonary diseaseJPRN-UMIN000026496Showa University5,000
尚未招募
不适用
The therapeutic efficacy of long acting beta2 stimulant in patients with early stage COPDPatients with early stage COPD screened by medical examinationJPRN-UMIN000016046Tokushima University Hospital20
未知
不适用
Effects of an alpha2 adrenergic agonist and a beta adrenergic antagonist on disturbance of visual function in glaucomaPrimary open-angle glaucoma (POAG)JPRN-jRCT1080222065Tohoku University60
招募中
不适用
The effect of add-on beta2 agonist in paitents with COPD treatd with tiotropiumJPRN-UMIN000003401Kyoto university hhospital, resipiratory medicine100
进行中（未招募）
1 期
Beta-agonist Efficacy and Tolerability as Adjuvant therapy in Myasthenia GravisMedDRA version: 21.1Level: PTClassification code 10028417Term: Myasthenia gravisSystem Organ Class: 10029205 - Nervous system disordersMyasthenia GravisEUCTR2019-000895-40-DKAarhus University Hospital30